{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:34:32Z","timestamp":1789187672213,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NICHD","award":["P01 HD070394"],"award-info":[{"award-number":["P01 HD070394"]}]},{"name":"Rolanette and Berdon Lawrence Disease Program of Texas"},{"name":"BCM Intellectual and Developmental Disabilities Research Center","award":["HD024064"],"award-info":[{"award-number":["HD024064"]}]},{"name":"Eunice Kennedy Shriver National Institute of Child Health & Human Development"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ymgme.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T18:44:29Z","timestamp":1425062669000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton"],"prefix":"10.1016","volume":"115","author":[{"given":"Shan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Rianon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbhirami","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Munivez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjin","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2009.223","article-title":"Treatment of Alport syndrome: beyond animal models","volume":"76","author":"Gross","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/ajmg.a.35540","article-title":"Assessment of bone mineral status in children with Marfan syndrome","volume":"158A","author":"Grover","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11420-006-9030-3","article-title":"Bone mineral density determinations by dual-energy X-ray absorptiometry in the management of patients with Marfan syndrome\u2014some factors which affect the measurement","volume":"3","author":"Giampietro","year":"2007","journal-title":"HSS J."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jbspin.2006.01.026","article-title":"Bone mineral density in Marfan syndrome. A large case\u2013control study","volume":"73","author":"Moura","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrd873","article-title":"Drugs targeting the renin\u2013angiotensin\u2013aldosterone system","volume":"1","author":"Zaman","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bone.2010.03.016","article-title":"Telmisartan alleviates rosiglitazone-induced bone loss in ovariectomized spontaneous hypertensive rats","volume":"47","author":"Ma","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0045","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","article-title":"Angiotensin II type 2 receptor blockade increases bone mass","volume":"284","author":"Izu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","article-title":"Angiotensin II accelerates osteoporosis by activating osteoclasts","volume":"22","author":"Shimizu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","article-title":"Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation \u2014 role of a local renin\u2013angiotensin system","volume":"159","author":"Garcia","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/ATVBAHA.109.187732","article-title":"Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells","volume":"29","author":"Tsubakimoto","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/00004872-200110000-00018","article-title":"Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen","volume":"19","author":"Mannisto","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"648537","DOI":"10.1155\/2012\/648537","article-title":"Expression of angiotensin II receptor-1 in human articular chondrocytes","volume":"2012","author":"Kawakami","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0080","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1073\/pnas.1219748110","article-title":"E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-beta in the bone microenvironment","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm1712","article-title":"Dimorphic effects of Notch signaling in bone homeostasis","volume":"14","author":"Engin","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0090","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/hmg\/ddn125","article-title":"Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome","volume":"17","author":"Napierala","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0095","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/j.1476-5381.2011.01702.x","article-title":"Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug","volume":"165","author":"Reuter","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0100","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology","volume":"112","author":"Higuchi","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL\u2013RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbrc.2007.06.017","article-title":"TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation","volume":"359","author":"Lamothe","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","article-title":"Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts","volume":"305","author":"Lee","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","article-title":"Angiotensin II drives the production of tumor-promoting macrophages","volume":"38","author":"Cortez-Retamozo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pharmthera.2008.02.007","article-title":"Role of bone marrow renin\u2013angiotensin system in the pathogenesis of atherosclerosis","volume":"118","author":"Fukuda","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1357-2725(02)00278-9","article-title":"Towards the understanding of the local hematopoietic bone marrow renin\u2013angiotensin system","volume":"35","author":"Haznedaroglu","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0140","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/jbmr.501","article-title":"Physiological function of the angiotensin AT1a receptor in bone remodeling","volume":"26","author":"Kaneko","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0145","article-title":"Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin","volume":"2","author":"Zhang","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0150","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1734-1140(12)70882-4","article-title":"Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs","volume":"64","author":"Donmez","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","article-title":"Activation of renin\u2013angiotensin system induces osteoporosis independently of hypertension","volume":"24","author":"Asaba","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2015.02.006_bb0160","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.3109\/07853890.2011.653396","article-title":"Immune mechanisms in angiotensin II-induced target-organ damage","volume":"44","author":"Luft","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0165","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0170","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1592\/phco.2005.25.9.1213","article-title":"Protective effects of angiotensin II interruption: evidence for antiinflammatory actions","volume":"25","author":"Dagenais","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.fob.2013.07.001","article-title":"Activating types 1 and 2 angiotensin II receptors modulate the hypertrophic differentiation of chondrocytes","volume":"3","author":"Tsukamoto","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ymgme.2015.02.006_bb0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/hr.2010.67","article-title":"Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy","volume":"33","author":"Sukumaran","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ymgme.2015.02.006_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.110.159525","article-title":"MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE","volume":"57","author":"Odenbach","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ymgme.2015.02.006_bb0190","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jss.2012.12.012","article-title":"Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms","volume":"183","author":"Nagasawa","year":"2013","journal-title":"J. Surg. Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921500061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921500061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T20:00:34Z","timestamp":1537819234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921500061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S109671921500061X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.02.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}